Eradivir Secures $10 Million in Private Financing
Continues to Advance Lead Antiviral Therapeutic EV25 WEST LAFAYETTE, Ind.–(BUSINESS WIRE)–Eradivir Inc., a clinical-stage biotechnology company that harnesses the power of the immune system to target and treat disease, today announced the recent closing of…